Overview

Maxigesic IV Phase 3 Bunionectomy Study

Status:
Completed

Trial end date:
2017-09-15

Target enrollment:

Participant gender:

Summary

The purpose of the study is to determine the clinical efficacy and safety of Maxigesic IV, acetaminophen IV, Ibuprofen IV versus placebo IV for the treatment of acute postoperative pain after bunionectomy

Phase:

Phase 3

Details

Lead Sponsor:

AFT Pharmaceuticals, Ltd.

Treatments:

Acetaminophen
Ibuprofen
Pharmaceutical Solutions